Results 91 to 100 of about 20,787 (190)

Gitelman and Bartter Syndrome in a Patient With Morbid Obesity: A Case Report and Literature Review

Clinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT We present a case study of a 34‐year‐old man with morbid obesity and a suspected Bartter–Gitelman spectrum tubulopathy (without genetic confirmation), weighing 135 kg, and with a BMI of 42.5 kg/m2, who was referred to the metabolic and bariatric surgery department due to morbid obesity to address abnormal electrolyte levels.
Solmaz Hasani, Alireza Rezapanah, Tooraj Zandbaf, Mohammad Javad Ghamari, Narges Mesbah   +4 more
wiley   +1 more source

Continuous subcutaneous insulin infusion therapy and multiple daily insulin injections in type 1 diabetes mellitus: a comparative overview and future horizons. [PDF]

, 2015
INTRODUCTION: Continuous subcutaneous insulin infusion (CSII) therapy is currently accepted as a treatment strategy for type 1 diabetes. Transition from multiple daily injection therapy (MDI; including basal-bolus regimens) to CSII is based on ...
Hovorka, R, Mohd-Thabit, HA
core   +1 more source

Severe Euglycemic Diabetic Ketoacidosis Requiring Intubation After Tirzepatide and SGLT2 Inhibitor Coadministration in a Patient With Type 1 Diabetes Mellitus From a Large Tertiary Care Centre in Karachi, Pakistan: A Case Report and Brief Review of the Literature

Clinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Euglycemic diabetic ketoacidosis (euDKA) is an uncommon but potentially life‐threatening complication that may arise in patients treated with incretin‐based therapies or Sodium–Glucose Cotransporter‐2 (SGLT2) inhibitors. We report a 41‐year‐old female with Type 1 Diabetes Mellitus (T1DM) who developed severe euDKA after initiating tirzepatide ...
Maliha Malik, Hammad Amjad, Khadija Malik, Muddassir Syed Saleem, Shanzay Akhtar, Muslehuddin Paracha, Mobeen Abid, Nabahat Shafi, Ahmed Asad Raza, Abedin Samadi, Samar Abbas Jaffri   +10 more
wiley   +1 more source

Perbandingan Profil Penggunaan Terapi Kombinasi Insulin pada Pasien Diabetes Melitus Tipe 2 di Unit Rawat Inap Rumah Sakit Umum Pusat (Rsup) Sanglah [PDF]

, 2013
Kombinasi insulin kerja menengah (Neutral Protamine Hagedorn/NPH) dengan insulin kerja pendek (Regular Human Insulin/RHI) dan kombinasi insulin kerja panjang (insulin glargine) dengan insulin kerja cepat (insulin aspart) adalah jenis kombinasi insulin ...
A, K. I. (Kartika), A, S. D. (Swastini), W, L. A. (Lestari)   +2 more
core  

Severe hypoglycaemia in adults with insulin-treated diabetes: impact on healthcare resources [PDF]

, 2016
Aims: To assess resource utilization associated with severe hypoglycaemia across three insulin regimens in a large phase 3a clinical programme involving people with Type 1 diabetes treated with basal–bolus insulin, people with Type 2 diabetes treated ...
Akram, Brod, Budnitz, Dailey, Davies, Donnelly, Evans, Foos, Frier, Frier, Fulcher, Garber, Geller, Gough, Graveling, Greco, Hammer, Harris, Harris, Heller, Heller, Hirsch, International Conference on Harmonisation, Kaneko, Kristensen, Lammert, Leese, Leiter, Levy, Lipska, Lundkvist, MacLeod, Mathieu, Meneghini, Onishi, Onishi, Philis-Tsimikas, Stratton, The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group, UK Hypoglycaemia Study Group, UK Prospective Diabetes Study (UKPDS) Group, Vexiau, Waugh, World Medical Association, Zinman   +44 more
core   +1 more source

Insulin‐Dependence and Survival in Pancreatic Neuroendocrine Tumors: Results From the US‐NTSG Group

Journal of Surgical Oncology, Volume 133, Issue 2, Page 153-160, February 2026.
ABSTRACT Introduction PNETs are rare pancreatic malignancies originating from islet cells and exhibit a strong co‐occurrence with Diabetes Mellitus (DM), associated with worse survival outcomes. However, studies have yet to delineate the impact of insulin dependent (IDDM) and non‐insulin dependent (NIDDM) on poor oncological outcomes. Methods Utilizing
Muhammad Bilal Mirza, Jordan J. Baechle, Paula Marincola Smith, Danish Ali, Mary Dillhoff, George Poultsides, Flavio G. Rocha, Clifford S. Cho, Emily R. Winslow, Ryan C. Fields, Shishir K. Maithel, Kamran Idrees   +11 more
wiley   +1 more source

South Asian Consensus Guideline: Use of insulin in diabetes during Ramadan

Indian Journal of Endocrinology and Metabolism, 2012
A person with diabetes mellitus (DM) has every right to perform the ritual of fasting during Ramadan. In daily practice we come across both type 1 and type 2 DM who wish to fast.
Md Faruque Pathan, Rakesh Kumar Sahay, Abdul Hamid Zargar, Syed Abbas Raza, A K Azad Khan, Mohammed Ashraf Ganie, Nazrul Islam Siddiqui, Firoz Amin, Osama Ishtiaq, Sanjay Kalra   +9 more
doaj   +1 more source

Healthcare resource utilization and related financial costs associated with glucose lowering with either exenatide or basal insulin: a retrospective cohort study [PDF]

, 2017
Aims Type 2 diabetes is a major health problem placing increasing demands on healthcare systems. Our objective was to estimate healthcare resource use and related financial costs following treatment with exenatide‐based regimens prescribed as once ...
Berni, Ellen R., Currie, Craig J., Holden, Sarah E., Jenkins-Jones, Sara, Morgan, Christopher Ll., Qiao, Qing   +5 more
core   +2 more sources

Pneumoperitoneum in two cats treated with trilostane for hypercortisolism

Veterinary Record Case Reports, Volume 14, Issue 1, February 2026.
Abstract This report describes two cases of pneumoperitoneum in cats receiving treatment for hypercortisolism and diabetes mellitus. Both cats presented with abdominal distention and lethargy and diagnoses of pneumoperitoneum were radiographically confirmed.
Nicholas James Kelly, Armando Sánchez‐Lara, Mike E. Herrtage, Hannah Wong, Andre Kortum   +4 more
wiley   +1 more source

Forum for injection techniques, India: The first Indian recommendations for best practice in insulin injection technique

Indian Journal of Endocrinology and Metabolism, 2012
Advances in the treatment of diabetes have led to an increase in the number of injectable therapies, such as human insulin, insulin analogues, and glucagon-like peptide-1 analogues.
Sanjay Kalra, Yatan Pal Singh Balhara, Manash P Baruah, Manoj Chadha, Hemraj B Chandalia, Subhankar Chowdhury, K M Prasanna Kumar, Sonal Modi, Shailesh Pitale, Rishi Shukla, Rakesh Sahay, Annamalai Sundaram, Ambika G Unnikrishnan, Subhash K Wangnoo   +13 more
doaj   +1 more source